Calton & Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Calton & Associates's BCAT Position: Q2 2026 in Review
Calton & Associates increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3.4% in Q2 2026, buying an estimated $5.73K and bringing the position to 11,442 shares worth $182K. The position accounts for 0.03% of the portfolio, ranked #412.
Calton & Associates first reported a position in BCAT in Q4 2021 and has held it in 18 quarters since. The position peaked at $422K in Q1 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Calton & Associates held 11,442 shares of BlackRock Capital Allocation Term Trust worth $182K as of Q2 2026.
- Calton & Associates bought 373 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $5.73K.
- BlackRock Capital Allocation Term Trust made up 0.03% of Calton & Associates's portfolio in Q2 2026, its #412 holding.
- Calton & Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and has held it in 18 quarters since.
- Calton & Associates's BlackRock Capital Allocation Term Trust position peaked at $422K in Q1 2024.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.